Cardiovascular disease is the leading cause of death worldwide and often originates in atherosclerosis, a chronic condition in which inflammation and fat deposits cause arteries to harden and narrow.

A CNIC-led study has identified imidazole propionate, a metabolite produced by gut bacteria, as a driver of atherosclerosis—a ...

A bacterially produced molecule circulates in the bloodstream and increases the risk of cardiovascular disease by hijacking ...

The discovery, made thanks to an experiment involving hundreds of bank employees in Spain, opens the door to new treatments beyond reducing cholesterol ...

The primary treatment for atherosclerosis is making lifestyle changes to help prevent the further build-up of plaque in your blood vessels. You may also need to take medications or receive a ...

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune activation and inflammation.

Drug treatment studies in children with the metabolic syndrome are rare in the literature. Atorvastatin therapy was used in children aged 10–17 years with LDL-C of 190 mg/dl or higher, including ...

A new study shows that cells in atherosclerotic blood vessels grow in a way that resembles tumor development. This finding ...

The U.S. atherosclerosis treatment market is driven by a high prevalence of cardiovascular diseases, pharmaceutical advancements, an aging population, lifestyle risks, and government health ...

Atherosclerosis is when plaque builds up in arteries, narrowing them and hindering blood flow. Read on to learn its causes and treatment measures.

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

Healthcare professionals play a crucial role in the prevention and treatment of atherosclerosis, starting in utero.